120 related articles for article (PubMed ID: 36945533)
21. The Cannabinoids Δ
Thapa D; Cairns EA; Szczesniak AM; Toguri JT; Caldwell MD; Kelly MEM
Cannabis Cannabinoid Res; 2018; 3(1):11-20. PubMed ID: 29450258
[No Abstract] [Full Text] [Related]
22. Cannabidiol skews biased agonism at cannabinoid CB
Navarro G; Reyes-Resina I; Rivas-Santisteban R; Sánchez de Medina V; Morales P; Casano S; Ferreiro-Vera C; Lillo A; Aguinaga D; Jagerovic N; Nadal X; Franco R
Biochem Pharmacol; 2018 Nov; 157():148-158. PubMed ID: 30194918
[TBL] [Abstract][Full Text] [Related]
23. Δ
Shum C; Dutan L; Annuario E; Warre-Cornish K; Taylor SE; Taylor RD; Andreae LC; Buckley NJ; Price J; Bhattacharyya S; Srivastava DP
Mol Cell Neurosci; 2020 Mar; 103():103463. PubMed ID: 31917333
[TBL] [Abstract][Full Text] [Related]
24. Biased Type 1 Cannabinoid Receptor Signaling Influences Neuronal Viability in a Cell Culture Model of Huntington Disease.
Laprairie RB; Bagher AM; Kelly ME; Denovan-Wright EM
Mol Pharmacol; 2016 Mar; 89(3):364-75. PubMed ID: 26700564
[TBL] [Abstract][Full Text] [Related]
25. Participation of endocannabinoids in rapid suppression of stress responses by glucocorticoids in neonates.
Buwembo A; Long H; Walker CD
Neuroscience; 2013 Sep; 249():154-61. PubMed ID: 23131711
[TBL] [Abstract][Full Text] [Related]
26. Cannabinoid receptor-mediated disruption of sensory gating and neural oscillations: A translational study in rats and humans.
Skosnik PD; Hajós M; Cortes-Briones JA; Edwards CR; Pittman BP; Hoffmann WE; Sewell AR; D'Souza DC; Ranganathan M
Neuropharmacology; 2018 Jun; 135():412-423. PubMed ID: 29604295
[TBL] [Abstract][Full Text] [Related]
27. In vitro and in vivo pharmacological activity of minor cannabinoids isolated from Cannabis sativa.
Zagzoog A; Mohamed KA; Kim HJJ; Kim ED; Frank CS; Black T; Jadhav PD; Holbrook LA; Laprairie RB
Sci Rep; 2020 Nov; 10(1):20405. PubMed ID: 33230154
[TBL] [Abstract][Full Text] [Related]
28. Allosteric and orthosteric pharmacology of cannabidiol and cannabidiol-dimethylheptyl at the type 1 and type 2 cannabinoid receptors.
Tham M; Yilmaz O; Alaverdashvili M; Kelly MEM; Denovan-Wright EM; Laprairie RB
Br J Pharmacol; 2019 May; 176(10):1455-1469. PubMed ID: 29981240
[TBL] [Abstract][Full Text] [Related]
29. Endocannabinoid signaling in hypothalamic-pituitary-adrenocortical axis recovery following stress: effects of indirect agonists and comparison of male and female mice.
Roberts CJ; Stuhr KL; Hutz MJ; Raff H; Hillard CJ
Pharmacol Biochem Behav; 2014 Feb; 117():17-24. PubMed ID: 24316201
[TBL] [Abstract][Full Text] [Related]
30. Mouse retinal ganglion cell signalling is dynamically modulated through parallel anterograde activation of cannabinoid and vanilloid pathways.
Jo AO; Noel JM; Lakk M; Yarishkin O; Ryskamp DA; Shibasaki K; McCall MA; Križaj D
J Physiol; 2017 Oct; 595(20):6499-6516. PubMed ID: 28766743
[TBL] [Abstract][Full Text] [Related]
31. Cannabinoid receptor signaling in progenitor/stem cell proliferation and differentiation.
Galve-Roperh I; Chiurchiù V; Díaz-Alonso J; Bari M; Guzmán M; Maccarrone M
Prog Lipid Res; 2013 Oct; 52(4):633-50. PubMed ID: 24076098
[TBL] [Abstract][Full Text] [Related]
32. Dual allosteric and orthosteric pharmacology of synthetic analog cannabidiol-dimethylheptyl, but not cannabidiol, on the cannabinoid CB
Bouma J; Broekhuis JD; van der Horst C; Kumar P; Ligresti A; van der Stelt M; Heitman LH
Biochem Pharmacol; 2023 Dec; 218():115924. PubMed ID: 37972874
[TBL] [Abstract][Full Text] [Related]
33. Circulating endocannabinoids and prospective risk for depression in trauma-injury survivors.
Fitzgerald JM; Chesney SA; Lee TS; Brasel K; Larson CL; Hillard CJ; deRoon-Cassini TA
Neurobiol Stress; 2021 May; 14():100304. PubMed ID: 33614866
[TBL] [Abstract][Full Text] [Related]
34. Cannabidiol Inhibits Endocannabinoid Signaling in Autaptic Hippocampal Neurons.
Straiker A; Dvorakova M; Zimmowitch A; Mackie K
Mol Pharmacol; 2018 Jul; 94(1):743-748. PubMed ID: 29669714
[TBL] [Abstract][Full Text] [Related]
35. Bidirectional alterations of hippocampal cannabinoid 1 receptors and their endogenous ligands in a rat model of alcohol withdrawal and dependence.
Mitrirattanakul S; López-Valdés HE; Liang J; Matsuka Y; Mackie K; Faull KF; Spigelman I
Alcohol Clin Exp Res; 2007 May; 31(5):855-67. PubMed ID: 17386072
[TBL] [Abstract][Full Text] [Related]
36. Sterol carrier protein-2: binding protein for endocannabinoids.
Liedhegner ES; Vogt CD; Sem DS; Cunningham CW; Hillard CJ
Mol Neurobiol; 2014 Aug; 50(1):149-58. PubMed ID: 24510313
[TBL] [Abstract][Full Text] [Related]
37. Fatty acid-binding proteins (FABPs) are intracellular carriers for Δ9-tetrahydrocannabinol (THC) and cannabidiol (CBD).
Elmes MW; Kaczocha M; Berger WT; Leung K; Ralph BP; Wang L; Sweeney JM; Miyauchi JT; Tsirka SE; Ojima I; Deutsch DG
J Biol Chem; 2015 Apr; 290(14):8711-21. PubMed ID: 25666611
[TBL] [Abstract][Full Text] [Related]
38. Mutation of putative GRK phosphorylation sites in the cannabinoid receptor 1 (CB1R) confers resistance to cannabinoid tolerance and hypersensitivity to cannabinoids in mice.
Morgan DJ; Davis BJ; Kearn CS; Marcus D; Cook AJ; Wager-Miller J; Straiker A; Myoga MH; Karduck J; Leishman E; Sim-Selley LJ; Czyzyk TA; Bradshaw HB; Selley DE; Mackie K
J Neurosci; 2014 Apr; 34(15):5152-63. PubMed ID: 24719095
[TBL] [Abstract][Full Text] [Related]
39. Development of an Indole-Amide-Based Photoswitchable Cannabinoid Receptor Subtype 1 (CB
Rodríguez-Soacha DA; Steinmüller SAM; Işbilir A; Fender J; Deventer MH; Ramírez YA; Tutov A; Sotriffer C; Stove CP; Lorenz K; Lohse MJ; Hislop JN; Decker M
ACS Chem Neurosci; 2022 Aug; 13(16):2410-2435. PubMed ID: 35881914
[TBL] [Abstract][Full Text] [Related]
40. Endocannabinoids regulate cocaine-associated memory through brain AEA-CB1R signalling activation.
Li H; Chen R; Zhou Y; Wang H; Sun L; Yang Z; Bai L; Zhang J
Mol Metab; 2022 Nov; 65():101597. PubMed ID: 36096452
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
